Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

MediWound (MDWD) Interest Expenses (2016 - 2025)

Historic Interest Expenses for MediWound (MDWD) over the last 13 years, with Q2 2025 value amounting to -$8.0 million.

  • MediWound's Interest Expenses fell 23234.93% to -$8.0 million in Q2 2025 from the same period last year, while for Sep 2025 it was -$8.0 million, marking a year-over-year decrease of 23234.93%. This contributed to the annual value of -$12.8 million for FY2024, which is 77711.42% down from last year.
  • As of Q2 2025, MediWound's Interest Expenses stood at -$8.0 million, which was down 23234.93% from -$2.4 million recorded in Q2 2024.
  • MediWound's Interest Expenses' 5-year high stood at -$399000.0 during Q2 2021, with a 5-year trough of -$9.5 million in Q4 2022.
  • For the 5-year period, MediWound's Interest Expenses averaged around -$2.3 million, with its median value being -$781000.0 (2022).
  • The largest annual percentage gain for MediWound's Interest Expenses in the last 5 years was 5324.12% (2022), contrasted with its biggest fall of 139842.52% (2022).
  • MediWound's Interest Expenses (Quarter) stood at -$635000.0 in 2021, then plummeted by 1398.43% to -$9.5 million in 2022, then surged by 90.61% to -$893000.0 in 2023, then crashed by 169.32% to -$2.4 million in 2024, then plummeted by 232.35% to -$8.0 million in 2025.
  • Its Interest Expenses stands at -$8.0 million for Q2 2025, versus -$2.4 million for Q2 2024 and -$893000.0 for Q2 2023.